Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
about
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesAdaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibilityBiology, systematics, and clinical manifestations of Zygomycota infectionsAntifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphoterLichtheimia species exhibit differences in virulence potential.Sudden death in a patient with bone marrow transplant by a fungus among usEfficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisHuman Fungal Pathogens of Mucorales and Entomophthorales.Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azolesDeconstructing host-pathogen interactions in Drosophila.The Drosophila melanogaster host model.Recent Advances in the Use of Drosophila melanogaster as a Model to Study Immunopathogenesis of Medically Important Filamentous Fungi.Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosisEfficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzaePharmacology and clinical use of voriconazole.Managing fungal and viral infections in pediatric leukemia.Update on the optimal use of voriconazole for invasive fungal infections.Pathogenesis of mucormycosis.Healthcare-associated mucormycosis.Fungal disease of the nose and sinuses: an updated overview.Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.A fatal case of gastrointestinal mucormycosis in immunosuppressed host.Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosisIntrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase.Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis.
P2860
Q28389719-3551151D-6495-439C-8F6B-363303F48795Q28606369-B71E71EA-D190-405F-ABB2-5AC9CFEFDA7EQ28656453-CC1975AE-5228-4768-8F0E-C80CA74DD9FEQ33559043-FAA696FB-A80B-42B4-8EF1-806809623B7FQ34315804-C3483B5A-3016-4264-9EF1-A6B19EAC85FCQ34387525-50E521BC-B080-4B58-AA12-3878E6D41731Q34572967-AE230BC5-AD7C-45C0-886C-143519C91317Q35065748-3158C6D5-F277-4D98-824E-B042F5FF32B1Q35245238-88EACCCA-4A2F-44F9-88CA-DC09C615CAC1Q35364288-A1793931-4D38-4B64-9B59-94D5EA2C6D6BQ35584615-AA67868A-FD51-455E-9C86-488462369975Q35665027-7654293B-7163-42F7-A705-079FCB5E885BQ35773518-E9027543-D89B-4795-98F2-FCAA6F8935BFQ35821280-CC5CCE47-D5E4-4FFC-BDBB-DF98DFBFF60DQ35848794-6E31D7F3-C32C-4BAF-B7CA-B869CD7CB916Q36290748-F6240BA3-8B6D-4300-BE03-32B78CEB1065Q36584655-AAD0E69B-9B85-4DAC-812A-365B2EB52B59Q36969836-30F4CC05-0F70-4EC4-8AAE-9CC0B8C5876CQ37223743-834F26D1-0E0E-4620-AA42-96ACB148406AQ37641375-2F37AF3E-EBCB-4929-9D63-0F1C9487AF4CQ37810281-BE0E72EE-F0C4-498A-A28B-3447AB358CF4Q37892901-8D4C345C-A944-47DC-B637-56242B48024BQ37976046-9F86C431-1734-4588-850D-03921B6968D4Q37976049-B51374CA-0C73-4BE6-9689-BDCD730EDD57Q38058471-CA3AF5EC-2E05-45EA-823E-569BA19C0257Q38866474-68B0EA12-8684-4FAD-94DC-63F4B18DCEC9Q40306219-31D48888-0076-434D-807C-31663EFF850AQ42075610-76240C57-47D2-40F6-9D2B-7BA9E1C59038Q42225441-960C2E41-6453-48A0-AFDC-BF7B7A258810Q42586695-78237955-DEB0-4DFF-8934-F7C8B6FAD7ADQ46256758-58AAF602-66B1-4425-94D5-F6753217F37AQ52645806-A63958FC-91AD-4E3E-8FFC-F611104A9E32
P2860
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@en
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@nl
type
label
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@en
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@nl
prefLabel
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@en
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@nl
P2093
P356
P1476
Increased virulence of Zygomyc ...... murine models of zygomycosis.
@en
P2093
Dimitrios P Kontoyiannis
George Samonis
Georgios Chamilos
Gregory A Lamaris
Ronen Ben-Ami
P304
P356
10.1086/597615
P407
P577
2009-05-01T00:00:00Z